Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

specific activity

  • The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on <sup>68</sup>Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer
    You have access
    The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer
    Hinke Siebinga, Judith olde Heuvel, Erik-Jan Rijkhorst, Jeroen J.M.A. Hendrikx and Berlinda J. de Wit-van der Veen
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 63-68; DOI: https://doi.org/10.2967/jnumed.122.264101
  • You have access
    Establishing 177Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer
    Wolfgang P. Fendler, Andreea D. Stuparu, Susan Evans-Axelsson, Katharina Lückerath, Liu Wei, Woosuk Kim, Soumya Poddar, Jonathan Said, Caius G. Radu, Matthias Eiber, Johannes Czernin, Roger Slavik and Ken Herrmann
    Journal of Nuclear Medicine November 1, 2017, 58 (11) 1786-1792; DOI: https://doi.org/10.2967/jnumed.117.193359
  • You have access
    The Advantage of Antibody Cocktails for Targeted Alpha Therapy Depends on Specific Activity
    Jordan B. Pasternack, Jason D. Domogauer, Alisha Khullar, John M. Akudugu and Roger W. Howell
    Journal of Nuclear Medicine December 1, 2014, 55 (12) 2012-2019; DOI: https://doi.org/10.2967/jnumed.114.141580
SNMMI

© 2025 SNMMI

Powered by HighWire